Catherine Labbe
Quebec, QC G1V4G5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives.
Journal: Current oncology (Toronto, Ont.)
Published: June 21, 2026
PD-L1 Negative Advanced Non-Small Cell Lung Cancer: Practice Patterns and Real-World Outcomes.
Journal: Current oncology (Toronto, Ont.)
Published: January 25, 2026
Lung Cancer in Patients With COPD: Predictors of Surgery and Long-Term Survival Following Lung Resection.
Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)
Published: January 12, 2026
Response to the letter to the Editor on "The Changing Landscape of Lung Cancer Resection Outcomes Over the Past Two Decades".
Journal: Clinical lung cancer
Published: November 04, 2025
Evaluating Decisions on Primary Sample Aliquot Volumes Based on Experience of Utilization: Recommendations for Today's Biobanks.
Journal: Biopreservation and biobanking
Published: October 30, 2025
A multi-ancestry genetic reference for the Quebec population.
Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2025
A multi-ancestry genetic reference for the Quebec population.
Journal: Nature communications
Published: May 25, 2025
The Changing Landscape of Lung Cancer Resection Outcomes Over the Past two Decades.
Journal: Clinical lung cancer
Published: March 05, 2025
Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec's University teaching hospitals.
Journal: Frontiers in oncology
Published: October 04, 2024
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol.
Journal: Clinical lung cancer
Published: April 09, 2024
Polygenic inheritance and its interplay with smoking history in predicting lung cancer diagnosis: a French-Canadian case-control cohort.
Journal: EBioMedicine
Published: January 30, 2024
Pembrolizumab Every 6 Weeks Versus Every 3 Weeks in Advanced Non-Small Cell Lung Cancer.
Journal: The oncologist
Published: March 07, 2023
Last Updated: 09/26/2026